First Quadrant’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Quadrant’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-337,943	Closed	-$18.2M	–	989
2017 Q4	$18.2M	Sell	337,943 -418	-0.1%	-$22.9K	0.34%	103
2017 Q3	$19.3M	Buy	338,361 +317,447	+1,518%	+$18.6M	0.37%	87
2017 Q2	$1.26M	Buy	20,914 +19	+0.1%	+$1.08K	0.03%	400
2017 Q1	$1.14M	Buy	+20,895	New	+$1.03M	0.02%	436

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Quadrant's BIVV Position: Q1 2018 in Review

First Quadrant sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 337,943 shares — an estimated $18.2M sold.

First Quadrant first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $19.3M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

First Quadrant reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
First Quadrant sold 337,943 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $18.2M.
First Quadrant first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
First Quadrant's Bioverativ Inc. Common Stock position peaked at $19.3M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Quadrant's 13F filing for Q1 2018, filed 20 Apr 2018.